ArticleJournal of cardiovascular translational research2018

Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.

Xavier Rossello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.